Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 2	2026-04-30		NCT05384015

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fundación GECP	15

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Complejo Hospitalario de Navarra	Pamplona	Spain	3
Hospital 12 de Octubre	Madrid	Spain	13
Hospital Clínic de Barcelona	Barcelona	Spain	25
Hospital Clínico de Valencia	Valencia	Spain	9
Hospital De Basurto	Bilbao	Spain	8
Hospital de la Santa Creu i Sant Pau	Barcelona	Spain	21
Hospital General Universitario de Alicante	Alicante	Spain	11
Hospital General Universitario de Valencia	Valencia	Spain	14
Hospital Parc Taulí	Barcelona	Spain	6
Hospital Son Espases	Palma de Mallorca	Spain	3
Hospital Universitari Vall d' Hebron	Barcelona	Spain	12
Hospital Universitario Fundación Jiménez Díaz	Madrid	Spain	24
Hospital Universitario Lucus Augusti	Lugo	Spain	18
Hospital Universitario Puerta de Hierro	Majadahonda	Spain	30
Hospital Universitario Regional de Málaga	Málaga	Spain	8
Hospitalario Universitario A Coruña	A Coruña	Spain	8
ICO Badalona, Hospital Germans Trias i Pujol	Badalona	Spain	10
ICO Girona, Hospital Josep Trueta	Girona	Spain	6